Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors

Table 3

Cox regression analyses: time until first dispensing date of levodopa for patients under 72 years, the final model (baseline in parentheses).

Variable	HR	CI	value
Age	1.054	(1.043, 1.065)	<0.001
Gender (male)	0.609	(0.541, 0.685)	<0.001
Drugs for diabetes (none)	0.824	(0.659, 1.03)	0.089
Drugs for hypertension (none)	0.816	(0.664, 1.003)	0.053
Drugs for atrial fibrillation (none)	0.888	(0.777, 1.014)	0.080
1^st prescription from specialist (not specialist)	2.003	(1.446, 2.775)	<0.001
Dopamine agonist user (MAO-B inhibitor user)	0.101	(0.088, 0.118)	<0.001